MIT Technology Review | Patients See Potential for Cures in Gene Editing with CRISPR MIT Technology Review That's the reason Carroll, 38, says he'd be in favor of gene editing embryos. He says the idea of correcting DNA errors in the next generation has no “ick factor” for him at all. “I have no compunctions about it,” says Carroll, who is a neuroscientist ... |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]ts-see-potential-for-cures-in-